Craft

Ginkgo Bioworks Holdings

Stock Price

$0.3

2024-07-16

Market Capitalization

$779.9 M

2024-07-16

Revenue

$251.5 M

FY, 2023

Ginkgo Bioworks Holdings Summary

Company Summary

Overview
Ginkgo Bioworks is a company that designs, engineers and develops living organisms from DNA codes. It offers enzyme discovery, protein production, metabolic engineering, strain optimization, and other services. The company caters to agriculture, biopharmaceutical, government, industrial, nutrition, and other sectors.
Type
Public
Status
Active
Founded
2008
HQ
Boston, MA, US | view all locations
Website
https://investors.ginkgobioworks.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jason Kelly
  • Austin Che
  • Reshma Shetty

    Reshma Shetty, Co-Founder & President, COO, Director

  • Tom Knight

    Tom Knight, Founder

    LocationsView all

    1 location detected

    • Boston, MA HQ

      United States

      27 Drydock Avenue, 8th Floor

    Ginkgo Bioworks Holdings Financials

    Summary Financials

    Revenue (Q1, 2024)
    $37.9M
    Net income (Q1, 2024)
    ($165.9M)
    Cash (Q1, 2024)
    $840.4M
    EBIT (Q1, 2024)
    ($178.0M)
    Enterprise value
    $174.0M

    Footer menu